Die Suchmaschine für Unternehmensdaten in Europa
EU-Förderung (3.929.699 €): Innovation bei der Modellierung von Placenta für die Gesundheit von Müttern und Föten Hor 28.08.2017 EU-Rahmenprogramm für Forschung und Innovation "Horizont"
Text
Innovation bei der Modellierung von Placenta für die Gesundheit von Müttern und Föten
“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together three different businesses; Mimetas (MIM) (organ-on-a-chip developer) as a beneficiary, and Moor, a clinical-technology specialist, and industrial global brand FujifFilm VisualSonics (FUJ) as partners. Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.
Geförderte Unternehmen:
| Firmenname | Förderungssumme |
| Action on Pre-Eclampsia | ? |
| Aston University | 273.288 € |
| Fundacion para La Investigacion del Hospital Universitario La Fe de La Comunidad Valenciana | 247.873 € |
| Institut National de la Sante et de la Recherche Medicale | 525.751 € |
| Katholieke Universiteit Leuven | 250.560 € |
| Mimetas B.V. | 510.749 € |
| St George's Hospital Medical School | 546.576 € |
| Universita Degli Studi Di Torino | 258.061 € |
| Universitaet Rostock | 249.216 € |
| Universiteit Maastricht | 255.374 € |
| University College Cork - National University of Ireland, Cork | 265.675 € |
| University of Dundee | 546.576 € |
Quelle: https://cordis.europa.eu/project/id/765274
Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider. Der letzte verfügbare Stand wird auf folgender Seite wiedergegeben: Action on Pre-Eclampsia, Evesham, Großbritannien.